Literature DB >> 6295262

Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.

M Del Rio, G H McCracken, J D Nelson, D Chrane, S Shelton.   

Abstract

Single-dose pharmacokinetics of ceftriaxone were determined in 19 patients with proven bacterial meningitis. The dosage was 50 mg of ceftriaxone per kg. The plasma concentration time curve declined in a biexponential manner. The mean peak plasma concentration was 207 micrograms/ml, and the elimination half-life was 4 h. In 12 patients, multiple-dose pharmacokinetics were determined after a loading dose of 75 mg of ceftriaxone per kg, followed by 50-mg/kg doses every 8 h in 5 patients or every 12 h in 7 patients. The mean peak plasma concentration was 230 micrograms/ml after the first dose and 263 micrograms/ml after the last dose. Of 12 patients, 5 had trough values that were larger after multiple doses than after a single dose. Mean penetration of ceftriaxone into cerebrospinal fluid was 3.1%. The median cerebrospinal fluid bactericidal titer against the patients pathogens was greater than 1:1,024 and less than 1:2,048. The drug was well tolerated without adverse effects.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6295262      PMCID: PMC183803          DOI: 10.1128/AAC.22.4.622

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  The two-compartment open-system kinetic model: a review of its clinical implications and applications.

Authors:  P M Loughnan; D S Sitar; R I Ogilvie; A H Neims
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

2.  CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.

Authors:  A J Sedman; J G Wagner
Journal:  J Pharm Sci       Date:  1976-07       Impact factor: 3.534

3.  A pharmacologic evaluation of penicillin in children with purulent meningitis.

Authors:  J P Hieber; J D Nelson
Journal:  N Engl J Med       Date:  1977-08-25       Impact factor: 91.245

4.  Hemophilus influenzae type b infections: recurrent disease due to ampicillin-resistant strains.

Authors:  G Delage; Y DeClerck; J Lescop; P Bery; F Shareck
Journal:  J Pediatr       Date:  1977-02       Impact factor: 4.406

5.  Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicol.

Authors:  N Uchiyama; G R Greene; D B Kitts; L D Thrupp
Journal:  J Pediatr       Date:  1980-09       Impact factor: 4.406

6.  Penicillin-insensitive pneumococci. Case report and review.

Authors:  G A Ahronheim; B Reich; M I Marks
Journal:  Am J Dis Child       Date:  1979-02

7.  Ampicillin-resistant H. influenzae subdural empyemia following successful treatment of apparently ampicillin-sensitive H. influenzae meningitis.

Authors:  W L Albritton; G Hammond; A R Ronald; S Hoban
Journal:  J Pediatr       Date:  1977-02       Impact factor: 4.406

8.  Microbioassay of antimicrobial agents.

Authors:  H J Simon; E J Yin
Journal:  Appl Microbiol       Date:  1970-04

9.  Meningitis due to Haemophilus influenzae type b resistant to both ampicillin and chloramphenicol.

Authors:  J F Kenny; C D Isburg; R H Michaels
Journal:  Pediatrics       Date:  1980-07       Impact factor: 7.124

10.  Ampicillin in Haemophilus influenzae meningitis. Clinicopharmacologic evaluation of intramuscular vs intravenous administration.

Authors:  H D Wilson; K C Haltalin
Journal:  Am J Dis Child       Date:  1975-02
View more
  25 in total

1.  Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli.

Authors:  W Kern; S L Kennedy; M Sachdeva; E R Sande; D Gunderson; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

2.  Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.

Authors:  B Barry; M Muffat-Joly; J Bauchet; F Faurisson; P Gehanno; J J Pocidalo; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

3.  Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Authors:  M M París; S M Hickey; M Trujillo; S Shelton; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

Review 4.  Antibiotics in neonatal infections: a review.

Authors:  V Fanos; A Dall'Agnola
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

5.  Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.

Authors:  K S Kim; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

Review 6.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

7.  Comparison of ceftriaxone and traditional therapy of bacterial meningitis.

Authors:  B L Congeni
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

8.  Treatment of bacterial meningitis with ceftizoxime.

Authors:  G D Overturf; D C Cable; D N Forthal; C Shikuma
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

Review 9.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

10.  Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges.

Authors:  R Nau; H W Prange; P Muth; G Mahr; S Menck; H Kolenda; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.